Tri-State Chinese American Chemical Society Successfully Held its Annual Symposium at Rutgers University
The Tri-State CACS held its annual symposium on June 16, 2007 in the Fiber Optics Auditorium at Rutgers University Busch Campus. About 150 people attended the symposium. The theme of the symposium was “Chemistry Frontiers: Challenges and Opportunities in Global Competition.”
In his opening remarks, Dr. Guodong Chen, president of Tri-State CACS, welcomed the speakers and the audience. He thanked the sponsors and volunteers for their support that made the symposium possible. He also reiterated that the mission of CACS was to promote the professional development of Chinese chemists in the US and to also act as a bridge in cross-Atlantic US-China cooperation in chemical and pharmaceutical endeavors. He highlighted recent achievements of the Tri-State CACS, citing the highly successful Tri-State CACS annual symposia in recent years, the 2nd International Drug Discovery R&D Forum in Beijing (May 2007), and the 1st Beijing International Pharmaceutical and Chemical Intellectual Property Forum (April 2006).
Prof. Longqin Hu, president-elect of the Tri-State CACS, and Dr. Daniel Wang presided the morning sessions. Dr. Mauricio Futran, vice president of Process Development at Bristol-Myer Squibb Co., delivered the keynote speech. He spoke on “Opportunities in Small Molecule Process Development,” describing a shift at BMS from the traditional linear, serial approach in process development to an integrated, parallel process that requires efficient incorporation of automated parallel data acquisition in the lab, on-line monitor of scale-up process, and multi-level models. This shift, according to Dr. Futran, had resulted in much faster process development at BMS.
The rest of the morning sessions focused on recent progress in drug discovery chemistry and processes. Dr. Srikanth Venkatraman, a senior principal scientist from Schering-Plough, described the discovery of a protease inhibitor for the treatment of hepatitis C viral infection. Dr. John Ellingboe, assistant vice president at Wyeth, spoke on the impact of new chemical and screening technologies on improving the quality of drug candidates and how the new technologies help reduce cycle time. Dr. Walter Korfmacher, a distinguished fellow at Schering-Plough, described mass spectrometry strategies for speeding the lead optimization process. The different perspectives from these leaders in their fields were very well received and they stimulated lively discussions with the audience.
The afternoon sessions were presided by Drs. Fangbiao Li and Yong Huang. The topics centered on cutting edge technologies and resources that have become available to chemical and pharmaceutical R&D. Speakers from Waters Corp., Thermo Fisher Scientific, and TASCON USA, Inc. talked about advances in instrumentation. Representatives from AstaTech, Tyger Scientific, and United Pharmatech introduced to the audience their outsourcing services for pharmaceutical and chemical industries.
Prof. Longqin Hu closed the symposium by thanking all the participants of the symposium for their support. He wished everyone well and hoped to see them in the future at Tri-State CACS organized activities.
一年一度的三州华美化学会年会将于六月十六日星期六在罗格斯大学布什校园的 Rutgers Fiber Optics Auditorium 举办。年会免费注册，向所有的华美化学会会员以及从事化学化工专业人士开放， 并为参加者提供免费早餐与中餐。
今年年会的主题是“化学之全球挑战与机遇”， 主讲人是美国大制药公司 Bristol-Myers Squibb 的副总裁 Mauricio Futran 博士。另有多位来自其它大制药公司与化工制药公司的高层管理人员与技术专家给于高水平的讲座，重在讨论全球竞争之下的挑战与机会，尤其是迅速兴起的中国外包行业里的技术分析与创业机会。 年会有三重目的：第一，加强会员与会员，以及会员与有兴趣的化学工作者们 之间的联系和沟通。第二，了解中美两国之间化学以及有关专业方面 的最新发展和动向。第三，有机会与制药公司的高层管理人员以及创业有成的成功人士沟通交流与请教。机会难得， 参加人数有限，欢迎有兴趣的朋友及早报名，不要错过这一交流机会。
建会二十六年多的华美化学会（ Chinese American Chemical Society ）是一个志愿者参与的，无政治倾向，非盈利的组织。学会建立了独树一帜的“导师项目”（ mentor program ），给新入行的专业人员以帮助和提携。学会的“青年学生化学奖”，每年给高中高年级学生提供奖学金，以鼓励高中生对化学以及有关专业的兴趣。最近，学会开始向会员们推荐移民方面的专家，以帮助会员们在移民以及法律方面的要求。 2006 年，三州华美化学会与国内合作，成功地在北京举办了《北京国际医药化学化工知识产权高峰会谈》，在国内外专业界引起了较大的反响。 对三州华美化学会有兴趣的朋友，请访问三州华美化学会的网页
http://www.tristatecacs.org / 或者 email to: email@example.com 。
Fiber Optics Materials Research Building,
Rutgers Busch Campus
101 Bevier Rd, Piscataway, NJ 08854
Tri-State Chinese American
Chemical Society to Hold Its Annual Symposium
on June 16 at the Rutgers Fiber Optics Auditorium, Rutgers Busch Campus
The Tri-State Chinese American Chemical Society will hold its annual
symposium on June 16, from 8:30 AM to 4 PM, at the Rutgers Fiber Optics
Auditorium, Fiber Optics Materials Research Building, Rutgers Busch Campus,
Piscataway ( Address: 101 Bevier Rd, Piscataway, NJ
08854). Travel d irections can be found at http://maps.rutgers.edu/directions.aspx?id=133 .
Parking is available in lots 51, 59, and 68 without permit (Lot 51: on
Bartholomew Rd., adjacent to Rutgers Federal Credit Union;
Lot 59: behind Engineering and Busch Student Center, accessed from Bowser
Rd; Lot 68: accessed from corner of Taylor Rd. & Bevier Rd., directly
by Fiber Optics & Busch Student Center). Registration is free. Free
breakfast and lunch will also be provided to all symposium participants.
The annual symposium serves the purpose of bringing the CACS members
and non-member Chinese American chemists together. The theme of this
year's symposium is “Chemistry Frontiers: Challenges and Opportunities
in Global Competition”. This year's keynote speaker will be Dr. Mauricio
Futran, Vice President of Process Research and Development at Bristol-Myers
Squibb. Other speakers include senior technical leaders and executive
managers from major pharmaceutical companies. The latest analytical technology
advances and start-up companies in the outsourcing business will also
be featured at the symposium.
Since its founding 26 years ago, the CACS, a volunteer-based, non-political,
non-profit professional organization has worked to address the common
interest and concerns of Chinese-American chemical professionals. It
has established a mentor program to help new comers gain quick footing
in their professional careers in the US. It has presented Young Chemist
Award annually to outstanding high school students to help cultivate
interests in chemical sciences.
Please register on-line at www.tristatecacs.org or
via email at info@tristatecacs.
org . Registration on-site is accepted but you are encouraged to register
before hand to ensure your seating and meal order. For more information,
please contact Longqin Hu @ 732-445-5291, Xiaoqiu Wu @ 609-240-9200,
or Sunny Wang @ 908-231-3648.
8:30 Registration / Breakfast & Coffee
(Session Chairs: Longqin Hu & Daniel Wang)
9:00 Opening Remarks Guodong Chen
9:10 Dr. Mauricio Futran, Vice President, Bristol-Myer
“Opportunities in Small Molecule Process
9:50 Dr. George Njoroge, Director, Schering-Plough
“Challenges & Successes in Discovering Protease Inhibitors for Treatment
of Hepatitis C Virus”
10:30 Coffee Break
10:50 Dr. John Ellingboe, Assistant
Vice President, Wyeth
“The Impact of New Chemical and Screening Technologies on Improving
the Quality of Drug Candidates and Reducing Cycle Time”
11:30 Dr. Walter Korfmacher, Distinguished Fellow,
“Speeding the Lead Optimization Process: Using Mass Spectrometry Strategies
to Increase the Throughput for ADME/PK Screening”
(Session Chairs: Fangbiao Li & Yong Huang)
1:00 Mr. Edward Aig, Principal Technical Support Specialist
and Laboratory Manager, Waters Corporation
“Ultra Performance LC TM Redefining Separation Science”
1:25 Dr. James Kapron, Product Specialist, Thermo Fisher
“Advances in Bioanalytical Method Robustness”
1:50 Dr. Limin Sun, Application Scientist, TASCON USA,
“ToF-SIMS - a Chemical Microscope: Applications in
the Biomedical and Pharmaceutical Industry”
2:15 Dr . Bing Yu, Chief Operating Officer, AstaTech,
“A Premier Provider of Advanced Chemistry Solution”
2:40 Ms. Ping Cao, Marketing Manager, Tyger Scientific,
“Key to Success - Tale of a Growing Tyger”
3:05 Mr. Michael Hui, Chief Executive Officer, Chempartner
“Integrated Service: Solution for the Future in Pharmaceutical Outsourcing”
3:30 Dr. Xiongwei Shi, Chief Executive Officer , United
“United Pharmatech's Strategies and Steps towards Meeting US Pharmaceutical
Company's Requirements for Outsourcing Service”
3:55 Closing Remarks Longqin Hu